Chemed Corp. (NYSE:CHE) insider Spencer S. Lee sold 1,000 shares of the business’s stock in a transaction on Friday, September 1st. The shares were sold at an average price of $197.46, for a total transaction of $197,460.00. Following the sale, the insider now directly owns 37,809 shares in the company, valued at approximately $7,465,765.14. The sale was disclosed in a legal filing with the SEC, which is available through the SEC website.

Shares of Chemed Corp. (CHE) traded up 0.05% during trading on Friday, hitting $197.38. 95,646 shares of the company’s stock were exchanged. The firm has a 50-day moving average price of $196.43 and a 200-day moving average price of $194.33. Chemed Corp. has a one year low of $132.92 and a one year high of $216.01. The stock has a market cap of $3.16 billion, a P/E ratio of 48.97 and a beta of 1.14.

Chemed Corp. (NYSE:CHE) last posted its quarterly earnings results on Tuesday, July 25th. The company reported $2.15 EPS for the quarter, beating the consensus estimate of $1.89 by $0.26. The business had revenue of $415.06 million during the quarter, compared to analyst estimates of $407.56 million. Chemed Corp. had a net margin of 4.16% and a return on equity of 26.18%. The company’s quarterly revenue was up 6.3% compared to the same quarter last year. During the same quarter in the previous year, the business posted $1.80 EPS. Equities research analysts expect that Chemed Corp. will post $8.21 EPS for the current fiscal year.

The business also recently declared a quarterly dividend, which will be paid on Friday, September 1st. Shareholders of record on Monday, August 14th will be paid a dividend of $0.28 per share. This is a positive change from Chemed Corp.’s previous quarterly dividend of $0.26. The ex-dividend date of this dividend is Thursday, August 10th. This represents a $1.12 dividend on an annualized basis and a yield of 0.57%. Chemed Corp.’s dividend payout ratio is presently 28.07%.

TRADEMARK VIOLATION WARNING: This piece was first posted by Watch List News and is the property of of Watch List News. If you are viewing this piece on another publication, it was illegally stolen and reposted in violation of U.S. and international copyright & trademark legislation. The original version of this piece can be viewed at https://www.watchlistnews.com/spencer-s-lee-sells-1000-shares-of-chemed-corp-che-stock/1536665.html.

A number of hedge funds and other institutional investors have recently modified their holdings of CHE. Acrospire Investment Management LLC bought a new position in shares of Chemed Corp. during the second quarter worth about $120,000. Glen Harbor Capital Management LLC increased its stake in shares of Chemed Corp. by 11.4% in the first quarter. Glen Harbor Capital Management LLC now owns 624 shares of the company’s stock worth $114,000 after buying an additional 64 shares during the period. Pacad Investment Ltd. increased its stake in shares of Chemed Corp. by 250.0% in the second quarter. Pacad Investment Ltd. now owns 700 shares of the company’s stock worth $143,000 after buying an additional 500 shares during the period. Zurcher Kantonalbank Zurich Cantonalbank increased its stake in shares of Chemed Corp. by 12.8% in the second quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 731 shares of the company’s stock worth $150,000 after buying an additional 83 shares during the period. Finally, TrimTabs Asset Management LLC increased its stake in shares of Chemed Corp. by 88.7% in the first quarter. TrimTabs Asset Management LLC now owns 732 shares of the company’s stock worth $134,000 after buying an additional 344 shares during the period. Institutional investors and hedge funds own 96.96% of the company’s stock.

CHE has been the topic of a number of analyst reports. BidaskClub cut shares of Chemed Corp. from a “buy” rating to a “hold” rating in a report on Wednesday, August 2nd. Zacks Investment Research upgraded shares of Chemed Corp. from a “hold” rating to a “buy” rating and set a $213.00 price target for the company in a research report on Wednesday, August 23rd. Royal Bank Of Canada reiterated a “hold” rating and issued a $208.00 target price on shares of Chemed Corp. in a research report on Wednesday, July 5th. Oppenheimer Holdings, Inc. upped their target price on shares of Chemed Corp. from $200.00 to $220.00 and gave the stock an “outperform” rating in a research report on Thursday, July 27th. Finally, TheStreet lowered shares of Chemed Corp. from a “b+” rating to a “c+” rating in a research report on Tuesday, July 25th. Three investment analysts have rated the stock with a hold rating and two have issued a buy rating to the stock. The stock presently has an average rating of “Hold” and a consensus target price of $214.00.

Chemed Corp. Company Profile

Chemed Corporation purchases, operates and divests subsidiaries engaged in various business activities. The Company operates through two segments: the VITAS segment (VITAS) and the Roto-Rooter segment (Roto-Rooter). The Company’s VITAS provides hospice and palliative care services to its patients through a network of physicians, registered nurses, home health aides, social workers, clergy and volunteers.

Insider Buying and Selling by Quarter for Chemed Corp. (NYSE:CHE)

Receive News & Ratings for Chemed Corp. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Chemed Corp. and related companies with Analyst Ratings Network's FREE daily email newsletter.